INVESTOR FAQS
The Minerva Neurosciences stock is traded on the NASDAQ Capital Market under the ticker symbol NERV.
Minerva Neurosciences’ headquarters are located at 1500 District Avenue, Burlington, MA 01803, U.S.A.
The main phone number is +1 (617) 600-7373
Minerva Neurosciences is incorporated in the state of Delaware.
Our fiscal year ends on December 31.
The CUSIP number for Minerva Neurosciences’ common stock is 603380205
Minerva Neurosciences does not currently have a direct stock purchase plan.
Our transfer agent is:
Computershare Trust Company, Inc.
www.computershare.com
US Phone: +1 877 373 6374
International Phone: +1 781 575 2879Address for first class, registered, and certified mail:
Computershare Investor Services
P.O. Box 43078
Providence, RI 02940 USAAddress for overnight delivery:
Computershare Investor Services
250 Royall Street
Canton, MA 02021 USA
If your address has changed, please contact Minerva Neurosciences' transfer agent, Computershare (contact information provided above).
If you have misplaced your stock certificates, please contact Minerva Neurosciences' transfer agent, Computershare (contact information provided above). There may be a fee involved for replacing lost stock certificates.
Our independent auditor is:
Deloitte & Touche LLP
100 Kimball Drive
Parsippany, NJ 07054
+1 (973) 602-6000
Minerva Neurosciences does not expect to declare or pay any cash or other dividends on our common stock.
Minerva Neurosciences’ SEC filings can be accessed on the SEC Filings section of our Investor Relations page or directly from the SEC at http://www.sec.gov.